Press Release Archive

(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EST on Tuesday, February 1, 2011. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Fourth Quarter 2010 Performance Report, to be issued that morning. To view and listen to the webcast and view the Performance Report, visit our

(BUSINESS WIRE)--Pfizer Animal Health today announced the completion of its acquisition of Synbiotics Corporation (Pinksheets SYNB.PK) on December 30, 2010, resulting in the cessation of trading of Synbiotics common stock.

Shareholders of record of Synbiotics’ common stock will receive written instructions, including a letter of transmittal, for exchanging their Synbiotics common stock for the merger consideration. Holders in "street" name should contact their broker to receive their merger consideration. It is estimated that Synbiotics common shareholders will be entitled to receive up to approximately $0.306 per share in cash in connection with the acquisition, of which approximately $0.019 per share will be held in escrow as a fund against which Pfizer may make claims for any losses arising from any breaches of Synbiotics' representations, warranties, covenants and agreements and similar customary matters

(BUSINESS WIRE)--The board of directors of Pfizer Inc. (NYSE: PFE) today declared a 20-cent first-quarter 2011 dividend on the company's common stock, payable March 1, 2011, to shareholders of record at the close of business on February 4, 2011. Pfizer increased the dividend by approximately 11 percent, to 20 cents from 18 cents per share. "This dividend increase is a testament to our commitment to enhance shareholder value and

(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced that Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) was introduced into the first childhood immunization program for pneumococcal disease (PD) in the developing world under the auspices of the Advance Market Commitment (AMC) when Nicaragua launched its program today. The AMC is an innovative program which involves private-public partnerships to help make

MADISON, N.J.--(BUSINESS WIRE)--At the height of this year's cold and flu season, Angie Harmon, mom of three, is teaming up with the makers of Children's Advil® to launch "Relieve My Fever" -- a contest that invites parents and their kids to sing the Children's Advil® rendition of the classic song "Fever" for a chance to win $15,000. The kid-friendly version of the song tells the story of mommy fighting her little one's fever and making her child feel

(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that a significantly higher proportion of patients with newly diagnosed chronic myeloid leukemia who were treated with bosutinib (39 percent) experienced a major molecular response (MMR), a secondary endpoint, compared with patients treated with imatinib (26 percent) in the intent-to-treat (ITT) population (p=0.002). However, the study did not meet its primary endpoint of superior

(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today it is planning regulatory submissions of bosutinib in patients with chronic myeloid leukemia (CML) based on data from a clinical program evaluating the compound in newly diagnosed and previously treated patients. These regulatory submissions are planned for 2011. Pfizer has begun the process of preparing a Marketing Authorization Application (MAA) for submission to the European

MADISON, N.J.--(BUSINESS WIRE)--Getting it all done while enjoying life takes the right attitude and energy. A new contest from the makers of Centrum® multivitamins seeks to find out how some women manage to stay energized to enjoy life and love to the max this holiday season. Despite a calendar full of parties to plan and gifts to wrap, there are always those special women who manage to get everything done with a smile on their face, and the makers of

MADISON, N.J.--(BUSINESS WIRE)--On the heels of the Institute of Medicine increasing the daily recommended intake of vitamin D to maintain bone health, Americans may be left wondering how to meet the new guidelines. Pfizer Consumer Healthcare, the makers of the #1 selling brand of calcium and vitamin D supplements, announces the launch of new Caltrate® Soft Chews, a great-tasting and convenient way to help reach the new, higher daily vitamin D goals